Lobe Sciences (Lobe Sciences) Dividend Payout Ratio : 0.00 (As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences Dividend Payout Ratio?

Lobe Sciences's dividend payout ratio for the months ended in Feb. 2024 was 0.00.

The historical rank and industry rank for Lobe Sciences's Dividend Payout Ratio or its related term are showing as below:

LOBEF's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-09), the Dividend Yield % of Lobe Sciences is 0.00%.

Lobe Sciences's Dividends per Share for the months ended in Feb. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Lobe Sciences Dividend Payout Ratio Historical Data

The historical data trend for Lobe Sciences's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Dividend Payout Ratio Chart

Lobe Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Dividend Payout Ratio

Get a 7-Day Free Trial

Lobe Sciences Quarterly Data
	Dec18	Mar19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Lobe Sciences's Dividend Payout Ratio

For the Biotechnology subindustry, Lobe Sciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lobe Sciences's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's Dividend Payout Ratio falls into.

Lobe Sciences Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Lobe Sciences's Dividend Payout Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Aug. 2023 )	/	EPS without NRI (A: Aug. 2023 )
	=	0	/	-0.032
	=	N/A

Lobe Sciences's Dividend Payout Ratio for the quarter that ended in Feb. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Feb. 2024 )	/	EPS without NRI (Q: Feb. 2024 )
	=	0	/	-0.008
	=	N/A

Lobe Sciences (OTCPK:LOBEF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Lobe Sciences Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences (Lobe Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

6YX0:Germany LOBE:Canada

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.